Mentor Contour Profile Gel假体:10年临床结局
这项前瞻性、开放标签、多中心临床研究纳入955名女性,评估Contour Profile Gel/MemoryShape乳房假体在初次隆乳、初次乳房再造及修正手术中的安全性和有效性。10年累积发生率显示,初次隆乳组Baker III/IV级包膜挛缩为3.6%,感染为0.7%,任何再手术为22.3%。结论认为该假体对至少22岁女性的初次及修正隆乳和乳房再造安全有效。
要点
- 初次隆乳组10年Baker III/IV级包膜挛缩累积发生率为3.6%,修正隆乳组为15.5%。
- 初次隆乳组10年任何再手术累积发生率为22.3%,初次乳房再造组为52.7%。
- 初次隆乳组10年感染累积发生率为0.7%,修正乳房再造组为2.9%。
核心结论
- 结果表明Contour Profile Gel/MemoryShape乳房假体对至少22岁女性的初次及修正隆乳和乳房再造安全有效。
研究设计与样本
- 前瞻性、开放标签、多中心临床研究,纳入955名女性受试者,包括初次隆乳572例、修正隆乳124例、初次乳房再造190例、修正乳房再造69例。
- 安全性基于所有并发症的发生率、严重程度和处理方法评估,终点按受试者和按假体两种方式分析。
主要发现
- 受试者水平Kaplan-Meier估计10年累积发生率:Baker III/IV级包膜挛缩,初次隆乳3.6%、修正隆乳15.5%、初次乳房再造14.3%、修正乳房再造16.4%。
- 感染发生率:初次隆乳0.7%、修正隆乳1.9%、初次乳房再造1.6%、修正乳房再造2.9%。
- 取出假体(伴或不伴更换)发生率:初次隆乳9.2%、修正隆乳25.9%、初次乳房再造34.1%、修正乳房再造49.0%。
- 取出假体并更换研究假体发生率:初次隆乳4.0%、修正隆乳10.8%、初次乳房再造16.7%、修正乳房再造27.9%。
- 任何再手术发生率:初次隆乳22.3%、修正隆乳35.0%、初次乳房再造52.7%、修正乳房再造59.7%。
关键数值与推荐
- 关键并发症终点按受试者水平以Kaplan-Meier法估计10年累积发生率。
- Baker III/IV级包膜挛缩、感染、取出假体、取出并更换研究假体、任何再手术均按四个队列分别报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contour Profile Gel/MemoryShape breast implants consist of a textured silicone elastomer shell filled with silicone gel. The objective of this clinical study was to assess the safety and effectiveness of Contour Profile Gel/MemoryShape breast implants in women who were undergoing primary breast augmentation, primary breast reconstruction, or revision surgery (revision-augmentation or revision-reconstruction). METHODS: This was a prospective, open-label, multicenter clinical study involving Contour Profile Gel/MemoryShape breast implants in 955 female subjects, including 572 primary augmentation, 124 revision-augmentation, 190 primary reconstruction, and 69 revision-reconstruction subjects. Safety was assessed based on the incidence, severity, and method of resolution of all complications. Endpoints were examined on both a per-subject and a per-implant basis. RESULTS: For the primary augmentation, revision-augmentation, primary reconstruction, and revision-reconstruction cohorts, the Kaplan-Meier estimated 10-year cumulative incidence rates for the key complications at the subject level were as follows: Baker grade III/IV capsular contracture, 3.6 (primary augmentation), 15.5 (revision-augmentation), 14.3 (primary reconstruction), and 16.4 (revision-reconstruction) percent; infection, 0.7 (primary augmentation), 1.9 (revision-augmentation), 1.6 (primary reconstruction), and 2.9 (revision-reconstruction) percent; explantation with or without replacement, 9.2 (primary augmentation), 25.9 (revision-augmentation), 34.1 (primary reconstruction), and 49.0 (revision-reconstruction) percent; explantation with replacement with study device, 4.0 (primary augmentation), 10.8 (revision-augmentation), 16.7 (primary reconstruction), and 27.9 (revision-reconstruction) percent; and any reoperation, 22.3 (primary augmentation), 35.0 (revision-augmentation), 52.7 (primary reconstruction), and 59.7 (revision-reconstruction) percent. CONCLUSION: The results of this study demonstrate that Contour Profile Gel/MemoryShape breast implants are safe and effective for primary and revision breast augmentation and reconstruction for women at least 22 years old.
引用
- Hammond DC, Canady JW, Love TR, et al. Mentor Contour Profile Gel Implants: Clinical Outcomes at 10 Years. Plast Reconstr Surg. 2017. PMID: 29176413. doi:10.1097/PRS.0000000000003846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。